$AVCO Avalon is leveraging its mRNA-based FLASH-CAR platform to develop autologous and universal CAR-NK technology and cellular therapies for the potential treatment of hematologic malignancies and solid tumors.
https://finance.yahoo.com/news/avalon-globoca...21173.html